Stock KLY KALYTERA THERAPEUTICS INC
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Kalytera Therapeutics Inc Toronto S.E.

Equities

KLY

CA48349P1036

End-of-day quote Toronto S.E.
Other stock markets
 		5-day change 1st Jan Change
- PTS -.--% Intraday chart for Kalytera Therapeutics Inc -.--% -.--%
2021 Claritas Pharmaceuticals : Updates Proposed Financing with Obsidian, Receives Australian Tax Credit, Starts Phase 1 Study of R-107 MT
2021 Claritas Pharmaceuticals, Inc. Announces Data from Study Demonstrating Effectiveness of Nitric Oxide in Patients with Severe Covid-19 Pneumonia as Validation of the Company’s Nitric Oxide-Releasing Compound, R-107 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
MODERNA, INC. Stock Moderna, Inc.
 45.51B -
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 38.52B
LONZA GROUP AG Stock Lonza Group AG
 38.13B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
 30.74B -
CELLTRION, INC. Stock Celltrion, Inc.
 26.03B
  1. Stock Market
  2. Equities
  3. CLAS.H Stock
  4. KLY Stock
  5. Charts Kalytera Therapeutics Inc
  6. Sector Chart